Resistance to activated protein C and digital thrombosis

Jeffrey A Rodgers¹, Drew R Engles, Richard S Idler

¹Indiana Hand Center, USA.

|August 16, 2002

Abstract:

Resistance to activated protein C is a newly described genetic coagulation disorder previously only reported in patients with venous thromboembolism or central arterial embolism (cerebral or coronary). We report this defect in association with digital artery thrombosis and describe the pathophysiology of this disorder.

Related Experiment Videos

Resistance to activated protein C and digital thrombosis

Related Concept Videos

Scaphoid excision and limited wrist fusion: a comparison of K-wire and circular plate fixation.

Volar fixation of dorsally displaced distal radius fractures using the 2.4-mm locking compression plates.

Contact Stress Elevations Following Acetabular Fracture Fixation are Associated With Radiographic Osteoarthritis At Minimum Two-Year Follow-Up.

Patterns and Timing of Local Recurrence in Benign Bone Tumors.

Reliability of Semi-Automated Volumetric Quantification of Knee Effusion Using MRI After Acl Injury.

Femoral Shaft Fragility Fractures: Peri-Implant Fracture Risk Mitigated by Femoral Neck Protection.

Pediatric Achilles Tendon Ruptures in the United States: an Evaluation of National Practice Patterns, Management Trends, Complications and 2-Year Failure Rates.

Effect of Postoperative Weightbearing on Intracapsular Femoral Neck Fractures Treated with The Femoral Neck System: A Comparative Cohort Study.

Prevalence of Alloimmunization Among Patients With Transfusion-Dependent Thalassemia and Sickle Cell Disease in Salmaniya Medical Complex, Bahrain.

A Study on the Clinical Phenotypes and Genetic Analysis of ENG Variants in Four Hereditary Hemorrhagic Telangiectasia Type 1 Families.

HLA One-Way Mismatch as a Definitive Risk Factor for Graft-versus-Host Disease and Mortality in Living Donor Liver Transplantation.

Does Tranexamic acid fix all bleeding in surgery?

Allele and haplotype frequencies in high-resolution typing of human leukocyte antigen -A,-B, -C, -DRB1, and -DQB1 in 263,542 Thai voluntary stem cell donors.

Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.

Related Experiment Videos

Resistance to activated protein C and digital thrombosis

Abstract:

Related Concept Videos

Related Articles